We recently reported a de novo acute myeloid leukemia (AML) patient harboring both BCR::ABL1 p190 isoform and RUNX1::MECOM fusion, a rare and high-risk molecular profile. The gene discussed is ABL1; the disease is acute myeloid leukemia.